Phase II Trials of Erlotinib or Gefitinib in Patients with Recurrent Meningioma

There are no established treatments for recurrent meningioma when surgical and radiation options are exhausted. The epidermal growth factor receptor (EGFR) is often over-expressed in meningiomas and may promote tumor growth. In open label, single arm phase II studies of the EGFR inhibitors gefitinib...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Norden, Andrew D., Raizer, Jeffrey J., Abrey, Lauren E., Lamborn, Kathleen R., Lassman, Andrew B., Chang, Susan M., Yung, W.K. Alfred, Gilbert, Mark R., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Cloughesy, Timothy F., Robins, H. Ian, Aldape, Kenneth, Dancey, Janet, Prados, Michael D., Lieberman, Frank, Wen, Patrick Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786190/
https://ncbi.nlm.nih.gov/pubmed/19562255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9948-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller